Nonalcoholic Fatty Liver Disease

The central purpose of the Nonalcoholic Fatty Liver Disease (NAFLD) SIG is to provide a forum to share ideas, foster collaboration and brainstorm together as an academy of basic and translational investigators. Our mission is to study the pathogenesis, diagnosis, natural history and development of therapeutics for nonalcoholic liver disease. The NAFLD SIG sponsors programs at the AASLD Annual Meeting, identifies emerging topics in NAFLD, and supports the educational mission of AASLD. policy.

SIG Leadership

Anna Mae Diehl,MD, FAASLD

Mazen Noureddin,  MD

Michelle Long,  MD, MSC


Staff Liaisons
Patricia Marshall
Akuender Dot
Linda Howard

Steering Committee Members
Grace L. Guo, MBBS, PhD, FAASLD
Vincent Wong, MD
Naim Alkhouri, MD
Ricketta Clark
Jörn M. Schattenberg, MD
Michelle Long, MD, MSc
Gopanandan Parthasarathy, MBBS
Nghiem Bao Ha, MD, MAS
Yaron Rotman, MD, MSc, FAASLD